01046nas a2200397   4500000000100000008004100001653002700042653001000069653002400079653000900103653001600112653001700128653001000145653002100155653001100176653001800187653002400205653001100229653002600240653002600266653002800292653001100320653001200331653000900343653001600352653001400368653001700382653003800399653002800437653003000465245005600495856006600551300001000617490000700627022001400634       2018                            d10aAdjuvants, Immunologic10aAdult10aAdvisory Committees10aAged10aBCG Vaccine10aBuruli ulcer10aChild10aChild, Preschool10aFemale10aGlobal health10aGuidelines as Topic10aHumans10aImmunization Programs10aImmunization Schedule10aImmunization, Secondary10aInfant10aleprosy10aMale10aMiddle Aged10aPregnancy10aTuberculosis10aTuberculosis, Multidrug-Resistant10aTuberculosis, Pulmonary10aWorld Health Organization00aBCG vaccines: WHO position paper – February 2018.  uhttp://apps.who.int/iris/bitstream/10665/260306/1/WER9308.pdf  a73-960 v93  a0049-8114